Skip to main content

Technological Constraints Restraining the Growth of the Global Urban Air Mobility Market

Urban air mobility (UAM) is an ideal form of alternate transportation and is expected to be witnessed not too far off in the future. With the roads becoming increasingly congested in cities, researchers are trying to develop better and enhanced means of daily commute for the population for safe travel. Urban air mobility is something that can serve as an advanced way to commute on a daily basis. With the progress of time and technology, urban air mobility witnessed major advancements.

 From 2015 to 2019, a number of the testing and development on the use cases of urban air mobility has taken place. Urban air mobility use cases (air taxi, air ambulance, airport shuttle, cargo aerial vehicle, and others) are expected to be introduced by 2024-2025 in the market.

 Urban air mobility, as a part of the future urban landscape, can be described as the system that enables on-demand, safe, highly automated, and passenger and cargo-carrying air transportation services in a metropolitan environment for manned aircraft and unmanned aircraft systems.

 According to the market intelligence published by BIS Research, “Global Urban Air Mobility (UAM) Market - Analysis and Forecast, 2023-2035”, the global urban air mobility market is expected to grow at a CAGR of 26.2% during 2023-2035. The market is projected to grow owing to the factors that are driving the market, including increasing use of UAVs in commercial and civil applications, increasing need for efficient transportation and logistics, and increasing environmental concerns and energy impacts.

One of the constraints in the urban air mobility market is  the weight of the battery. This  is one of the reasons hindering the growth of the eVTOL aircraft in the urban air mobility market. The weight of the battery is still an issue for lightweight flying vehicles, as they cannot carry heavy batteries. Effectively, 30% of a flying vehicle’s weight must include the weight of batteries and energy stored. The limited capacity of batteries to support the functioning of eVTOL aircraft for long flight time is obstructing the adoption of eVTOL aircraft. Majorly, the li-ion battery is preferred, and its cost is expected to be $100/kWh-$150/kWh by 2025. Complex software systems for validation and certification is another technological challenge for the growth of the urban air mobility market.

 In addition, the eVTOL aircraft have three types of energy sources, which include battery, electric hybrid, and hydrogen. The electric/battery and electric hybrid together constitute of 97.69% of the total energy sources of eVTOL aircraft. The majority of the eVTOL aircraft manufactured by the companies are electric, with a market share of 71.54% of the total aircraft manufactured.

 The demand for electric hybrid eVTOL aircraft is increasing as they can fly on fossil fuels as well as on batteries. Electric hybrid aircraft holds a market share of 26.15% following electric eVTOL aircraft. Moreover, the eVTOL aircraft use hydrogen to generate electricity for the aircraft, and it holds 2.31% of the total eVTOL energy sources market. The companies that are manufacturing electric/hydrogen eVTOL aircraft are Avianovations, Supervolant, and Urban Aeronautics, Ltd.

Comments

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...